---
title: "Ishita Drugs & Industries Ltd (524400) — Share Price, Financials & Analysis"
symbol: "524400"
company: "Ishita Drugs & Industries Ltd"
canonical: "https://tapetide.com/stocks/524400"
isin: "INE806D01016"
nse_symbol: "ISHITADRUGSINDUSLTD"
bse_code: "524400"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 22.1
generated_at: "2026-09-13T18:38:01.253Z"
---

# Ishita Drugs & Industries Ltd (524400)

Canonical page: https://tapetide.com/stocks/524400

## Company

- **NSE Symbol:** ISHITADRUGSINDUSLTD
- **BSE Code:** 524400
- **ISIN:** INE806D01016
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 1997-12-05
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** ishitadrugs.com

## About

Incorporated in 1992, Ishita Drugs & Industries 
Ltd is engaged in the manufacturing of various APIs and drug intermediates[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:44:57.238994Z.

- **Market Cap:** ₹22.1 Cr
- **Classification:** Microcap
- **P/E (reported):** 31.4
- **EPS (TTM):** ₹2.38
- **EPS (reported):** ₹2.5
- **Book Value:** ₹38.69
- **Price to Book:** 1.91
- **Dividend Yield:** 0%
- **ROE:** 6.73%
- **ROCE:** 9.81%
- **Debt to Equity:** 0.01
- **Revenue (yearly):** ₹15.1 Cr
- **Net Income:** ₹0.8 Cr
- **EBITDA:** ₹1.2 Cr
- **52-Week High:** ₹90.85
- **52-Week Low:** ₹66
- **RSI (14):** 51.05

## Tapetide Score

- **Score:** 51 / 100
- **Score date:** 2026-09-04
- **Archetype:** No Dominant Pattern
- **What it means:** The three pillars do not combine into a recognisable pattern. Read them individually rather than looking for one story — the lack of a pattern is itself the finding.
- **Pillar profile:** Quality: Average · Valuation: Expensive · Momentum: Flat
- **Percentile:** 52 (of 4473 scored stocks)
- **Confidence:** 98%
- **Data coverage:** 95%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 85.47 | 9% |
| growth | 9.96 | 9% |
| momentum | 54.65 | 12% |
| ownership | 50 | 24% |
| quality | 58.38 | 22% |
| valuation | 42.48 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has reduced debt.
- Company is almost debt free.

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 1.00% over past five years.
- Company has a low return on equity of 7.72% over last 3 years.
- Earnings include an other income of Rs.0.43 Cr.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 207.69% | 84.91% | 27.27% |
| ebitda margin growth | 0% | -6.08% | 6.64% | -2.85% |
| net income growth | 0% | -11.11% | 10% | -1% |
| revenue growth | -3.03% | -1.31% | 7% | 1% |
| roce | — | -12.95% | -9.42% | 10.67% |
| roe | — | -16.4% | 7.44% | -28.1% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 4.4 | 3.21 | 4.5 | 3.03 | 3.27 | 4.13 | 4.56 | 5.4 | 3.07 | 3.14 | 3.06 | 3.15 |
| Expenses | 4.18 | 2.99 | 4.2 | 2.86 | 3.03 | 3.83 | 4.27 | 5.06 | 2.89 | 3 | 2.96 | 2.84 |
| Operating Profit | 0.22 | 0.22 | 0.3 | 0.17 | 0.24 | 0.3 | 0.29 | 0.34 | 0.18 | 0.14 | 0.1 | 0.31 |
| OPM % | 5 | 6.85 | 6.67 | 5.61 | 7.34 | 7.26 | 6.36 | 6.3 | 5.86 | 4.46 | 3.27 | 9.84 |
| Other Income | 0.1 | 0.01 | 0.1 | 0.06 | 0.05 | 0.07 | 0.16 | 0.09 | 0.07 | 0.1 | 0.22 | 0.04 |
| Interest | 0.01 | 0.04 | 0.02 | 0.01 | 0 | 0.02 | 0.04 | 0.02 | 0 | 0.02 | 0.02 | 0 |
| Depreciation | 0.03 | 0.03 | 0.01 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.05 |
| Profit before tax | 0.28 | 0.16 | 0.37 | 0.19 | 0.26 | 0.32 | 0.38 | 0.38 | 0.22 | 0.19 | 0.28 | 0.3 |
| Tax % | 25 | 25 | 24.32 | 26.32 | 23.08 | 25 | 23.68 | 23.68 | 36.36 | 21.05 | 35.71 | 23.33 |
| Net Profit | 0.21 | 0.12 | 0.28 | 0.15 | 0.19 | 0.24 | 0.29 | 0.3 | 0.14 | 0.16 | 0.18 | 0.23 |
| EPS in Rs | 0.7 | 0.4 | 0.94 | 0.5 | 0.64 | 0.8 | 0.97 | 1 | 0.47 | 0.54 | 0.6 | 0.77 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 6.9 | 9.09 | 14.83 | 13.95 | 14.09 | 12.07 | 15.19 | 15 | 14.66 | 12.42 |
| Expenses | 6.45 | 8.57 | 14.07 | 13.03 | 13.01 | 11.31 | 14.28 | 14.01 | 13.89 | 11.69 |
| Operating Profit | 0.45 | 0.52 | 0.76 | 0.92 | 1.08 | 0.76 | 0.91 | 0.99 | 0.77 | 0.73 |
| OPM % | 6.52 | 5.72 | 5.12 | 6.59 | 7.67 | 6.3 | 5.99 | 6.6 | 5.25 | 5.88 |
| Other Income | 0.12 | 0.16 | 0.16 | 0.31 | 0.11 | 0.2 | 0.28 | 0.34 | 0.47 | 0.43 |
| Interest | 0.11 | 0.06 | 0.03 | 0.03 | 0.02 | 0.05 | 0.09 | 0.07 | 0.06 | 0.04 |
| Depreciation | 0.14 | 0.16 | 0.18 | 0.15 | 0.13 | 0.13 | 0.11 | 0.11 | 0.1 | 0.13 |
| Profit before tax | 0.32 | 0.46 | 0.71 | 1.05 | 1.04 | 0.78 | 0.99 | 1.15 | 1.08 | 0.99 |
| Tax % | 25 | 26.09 | 23.94 | 20.95 | 23.08 | 25.64 | 24.24 | 25.22 | 27.78 | — |
| Net Profit | 0.25 | 0.35 | 0.55 | 0.83 | 0.8 | 0.58 | 0.75 | 0.87 | 0.78 | 0.71 |
| EPS in Rs | 0.84 | 1.17 | 1.84 | 2.78 | 2.68 | 1.94 | 2.51 | 2.91 | 2.61 | 2.38 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 |
| Reserves | 2.82 | 3.07 | 3.42 | 3.97 | 4.8 | 5.61 | 6.18 | 6.93 | 7.8 | 8.58 |
| Borrowings | 0.01 | 0.13 | 0.2 | 0.29 | 0.04 | 0 | 0.96 | 0 | 3.9 | 0.08 |
| Other Liabilities | 1.37 | 0.97 | 1.73 | 2.3 | 1.43 | 2.66 | 1.27 | 0.89 | 1.6 | 0.95 |
| Total Liabilities | 7.19 | 7.16 | 8.34 | 9.55 | 9.26 | 11.26 | 11.4 | 10.81 | 16.29 | 12.6 |
| Fixed Assets | 1.02 | 1.19 | 1.3 | 1.14 | 1 | 0.88 | 0.89 | 0.8 | 0.88 | 0.88 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.75 |
| Investments | 2.7 | 3.15 | 4.04 | 5.29 | 3.11 | 4.06 | 3.39 | 3.34 | 3.87 | 4.45 |
| Other Assets | 3.47 | 2.82 | 3 | 3.12 | 5.15 | 6.32 | 7.12 | 6.67 | 11.54 | 5.52 |
| Total Assets | 7.19 | 7.16 | 8.34 | 9.55 | 9.26 | 11.26 | 11.4 | 10.81 | 16.29 | 12.6 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0.52 | 0.72 | 0.79 | 1.05 | -0.67 | 3.08 | -2.9 | 2.12 | -3.64 | 3.92 |
| Cash from Investing Activity | -0.55 | -0.69 | -1.06 | -1.15 | 2.45 | -0.93 | 0.59 | 0.13 | -0.67 | -2.24 |
| Cash from Financing Activity | -1.05 | 0.05 | 0.09 | 0.09 | -0.24 | 0 | 1.05 | -0.87 | 4.33 | -3.81 |
| Net Cash Flow | -1.08 | 0.08 | -0.19 | -0.01 | 1.54 | 2.14 | -1.25 | 1.38 | 0.02 | -2.13 |
| Free Cash Flow | 0.48 | 0.41 | 0.52 | 1.04 | -0.67 | 3.06 | -3.03 | 2.09 | -3.82 | 2.07 |
| CFO/OP | 144 | 160 | 152 | 138 | -73 | 285 | -382 | 233 | -368 | 509 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 96.35 | 43.38 | 47.38 | 32.24 | 39.77 | 13.99 | 54.43 | 16.82 | 46.23 | 25.15 |
| Inventory Days | 51.49 | 55.56 | 42.2 | 18.49 | 23.06 | 34.81 | 68.22 | 34.27 | 149.21 | 32.57 |
| Days Payable | 108.49 | 43.21 | 78.7 | 60.25 | 34.76 | 73.22 | 36.67 | 14.87 | 31.78 | 19.83 |
| Cash Conversion Cycle | 39.35 | 55.72 | 10.88 | -9.52 | 28.07 | -24.41 | 85.99 | 36.22 | 163.66 | 37.89 |
| Working Capital Days | 56.68 | 32.27 | 8.03 | -10.83 | 29.83 | -27.46 | 42.94 | 21.87 | 30.17 | 43.82 |
| ROCE % | 4.77 | 7.16 | 8.12 | 10.68 | 14.32 | 12.9 | 8.86 | 10.77 | 9.91 | 8.66 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 49.38% | 49.38% | 49.42% | 49.8% | 49.8% | 49.85% | 49.91% | 49.92% | 49.96% | 50.04% | 50.04% | 50.04% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 46.07% | 47.04% | 47.48% | 47.51% | 47.17% | 46.89% | 46.89% | 46.76% | 46.63% | 46.33% | 47.37% | 47.89% |
| Others | 4.55% | 3.58% | 3.09% | 2.69% | 3.03% | 3.27% | 3.2% | 3.33% | 3.42% | 3.63% | 2.6% | 2.07% |
| No. of Shareholders | 5134 | 5283 | 5351 | 5272 | 5555 | 5412 | 5398 | 5341 | 5320 | 5263 | 5194 | 5146 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Sell
- **Buy / Neutral / Sell:** 5 / 7 / 7

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 73.16 | Buy |
| EMA (10) | 73.43 | Buy |
| SMA (20) | 73.41 | Buy |
| EMA (20) | 73.52 | Buy |
| SMA (50) | 73.81 | Sell |
| EMA (50) | 74.09 | Sell |
| SMA (100) | 75.98 | Sell |
| EMA (100) | 74.7 | Sell |
| SMA (200) | 74.6 | Sell |
| EMA (200) | 75.36 | Sell |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 50.34 | Neutral |
| MACD (12,26,9) | -0.19 | Buy |
| Stochastic (14,3,3) | 54.49 | Neutral |
| ADX (14) | 11.83 | Neutral |
| Williams %R (14) | -48.17 | Neutral |
| ATR (14) | 2.28 | High Volatility |
| ROC (12) | -0.34 | Sell |
| Stoch RSI (14) | 64.01 | Neutral |
| UO (7,14,28) | 50.14 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-31 | [Weblink Intimation Letter To The Shareholders](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=407299ce-3547-43ee-9041-79bf8741929c.pdf) |
| 2026-08-27 | [INTIMATION ABOUT THE BOOK CLOSURE FOR 33RD ANNUAL GENERAL MEETING (AGM)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d3651f4c-6f7e-4c75-9d74-287cf36a6f1b.pdf) |
| 2026-08-27 | [INTIMATION OF E- VOTING AS PER THE REGULATION 44 OF SEBI (LODR) REGULATION 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=87ddf022-a9c9-4cea-a8a6-ab9bc96f5811.pdf) |
| 2026-08-27 | [NOTICE OF 33RD ANNUAL GENERAL MEETING (AGM) ALONG WITH THE E-VOTING PERIOD](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=50a7c816-f2bf-4e15-bd2b-da73bc52444c.pdf) |
| 2026-08-27 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12777051-a779-4cd6-8440-856404748ae8.pdf) |
| 2026-08-08 | [Board Meeting Outcome for Outcome Of Board Meeting Held On 08Th August 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a95a9af8-b24c-409c-b82a-c2e7fd194603.pdf) |
| 2026-08-08 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d07d13d4-bcde-425a-bdf5-52647ca3ce38.pdf) |
| 2026-07-31 | [Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (LODR) Regulations 2015 For The Quarter Ended 30Th June 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=feb5f6aa-0f96-4eea-b856-83c665d477f0.pdf) |
| 2026-07-09 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f232a16d-b309-4d99-8c8c-00bccc76d800.pdf) |
| 2026-06-27 | [Closure of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=078475e2-a48e-4901-adb2-40f74220dff6.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-08 | [Outcome Of Board Meeting Held On 08H August 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=32ca9ff7-8d04-4a8d-8877-a8edf2cf71c9.pdf) |
| 2026-05-30 | [Outcome Of Board Meeting Held On 30Th May 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=37fe981c-4f14-49ac-b27d-fc0c04d4ae13.pdf) |
| 2026-02-07 | [Outcome Of Board Meeting Held On 07Th February 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=752fa77d-636e-4779-83db-40a91d39fae5.pdf) |
| 2025-11-11 | [Outcome Of Board Meeting Held On 11Th November 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e8412bd-9019-4a24-8abc-1c656c0d3418.pdf) |
| 2025-08-12 | [Outcome Of Board Meeting Held On 12Th August 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c22a1ddd-c486-4b0f-a144-21645080c660.pdf) |
| 2025-05-30 | [Outcome Of Board Meeting Held On 30Th May 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=82b154bc-b5b5-42f6-8ad1-ffb292cedb40.pdf) |
| 2025-02-13 | [Outcome Of Board Meeting Held On 13Th February 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48c1d612-984b-4d00-baa7-dec2ed2817a5.pdf) |
| 2024-11-12 | [Outcome Of Board Meeting Held On 12Th November, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d2a21c1-aa99-478c-a74b-9d9ff3c0c95b.pdf) |
| 2024-08-13 | [Outcome Of Board Meeting Held On 13Th August, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=34ca7ead-6503-4c28-8819-be891c60dcd8.pdf) |
| 2024-05-30 | [Outcome Of Board Meeting Held On 30Th May, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a8890644-b9ab-4d77-a555-38fef353e6f5.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 8 Jan - RTA certificate confirming dematerialisation processing for Ishita Drugs for quarter ended 31 Dec 2025. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 8 Jan - RTA certificate confirming dematerialisation processing for Ishita Drugs for quarter ended 31 Dec 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/57b07a6a-8acc-44ff-85c6-931bb635e262.pdf) |
| 7 Feb - Approved unaudited quarterly and nine-month results; Schedule M upgrades: Rs65L civil, Rs100L capex. | [Board Meeting Outcome for Outcome Of Board Meeting Held On 07Th February, 2026 7 Feb - Approved unaudited quarterly and nine-month results; Schedule M upgrades: Rs65L civil, Rs100L capex.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/44446c1e-58fe-4562-8dee-e17753ea8672.pdf) |
| 6 February 2026 - ASA & Associates LLP appointed internal auditor for financial year 2026-27, effective February 6, 2026. | [Change in Auditors 6 February 2026 - ASA & Associates LLP appointed internal auditor for financial year 2026-27, effective February 6, 2026.](https://nsearchives.nseindia.com/corporate/VASADENTICITY_06022026191144_Intimation_of_internal_auditor.pdf) |
| 6 February 2026 - Approved unaudited Q3/9M FY26 results to Dec 31, 2025; standalone 9M PAT Rs941.99L; appointed internal auditor. | [Outcome of Board Meeting 6 February 2026 - Approved unaudited Q3/9M FY26 results to Dec 31, 2025; standalone 9M PAT Rs941.99L; appointed internal auditor.](https://nsearchives.nseindia.com/corporate/VASADENTICITY_06022026183552_outome_of_board_meeting_finall.pdf) |
| 30 Jan - Board meeting on 07-Feb-2026 to approve unaudited results for quarter ended 31-Dec-2025; trading window closed. | [Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (LODR) Regulations, 2015 For The Quarter Ended 31St December, 2025 30 Jan - Board meeting on 07-Feb-2026 to approve unaudited results for quarter ended 31-Dec-2025; trading window closed.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ef8defe8-45d2-4c5a-b10d-b89fec3a10b9.pdf) |
| 3 February 2026 - Board meeting Feb 06, 2026 to approve unaudited Q3 and 9M results ended Dec 31, 2025; trading window closed. | [Updates 3 February 2026 - Board meeting Feb 06, 2026 to approve unaudited Q3 and 9M results ended Dec 31, 2025; trading window closed.](https://nsearchives.nseindia.com/corporate/VASADENTICITY_03022026132930_Intimation_of_Board_Meetingg.pdf) |
| 28 Apr - Company confirms it is not a large corporate for FY 2025-26 under SEBI debt circulars. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 28 Apr - Company confirms it is not a large corporate for FY 2025-26 under SEBI debt circulars.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e1af3685-7a0b-4396-8204-0d2d9e93bd9e.pdf) |
| 28 Apr - Company confirms it is not a large corporate for FY 2025-26 under SEBI debt circulars. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 28 Apr - Company confirms it is not a large corporate for FY 2025-26 under SEBI debt circulars.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/e1af3685-7a0b-4396-8204-0d2d9e93bd9e.pdf) |
| 27 Feb - Ishita Pharmaceuticals acquired 390 shares (0.01%) on Feb 26, 2026; holding rises to 32,642 (1.09%). | [Disclosure Under Regulation 29(2) Of SEBI (SAST) Regulations, 2011 27 Feb - Ishita Pharmaceuticals acquired 390 shares (0.01%) on Feb 26, 2026; holding rises to 32,642 (1.09%).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a902a4e2-cea6-403b-a255-3e3883b41cf3.pdf) |
| 24 Feb - Ishita Pharmaceuticals bought 506 shares (0.02%), raising holding to 32,252 (1.08%), on Feb 24, 2026. | [Disclosure Under Regulation 29(2) Of SEBI (SAST) Regulations, 2011 24 Feb - Ishita Pharmaceuticals bought 506 shares (0.02%), raising holding to 32,252 (1.08%), on Feb 24, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/93823562-2a06-4b05-9ddc-153e38aa231f.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://nsearchives.nseindia.com/corporate/VASADENTICITY_18112025123354_Intimation_of_transcript.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://nsearchives.nseindia.com/corporate/DENTALKART_20112024155841_Transcript_Intimation.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://nsearchives.nseindia.com/corporate/DENTALKART_07112023210904_InvestorPresentationH1FY24.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://nsearchives.nseindia.com/corporate/DENTALKART_10112023183844_TranscriptEarningCallHY1FY24.pdf) |
| May 2025 | [Concall - May 2025](https://nsearchives.nseindia.com/corporate/VASADENTICITY_26052025171954_Intimation_of_Transcript_of_Conference_Call_Signed.pdf) |
| May 2024 | [Concall - May 2024](https://nsearchives.nseindia.com/corporate/DENTALKART_27052024124344_TranscriptEarningCallFY2324.pdf) |
| Mar 2025 | [Concall - Mar 2025](https://nsearchives.nseindia.com/corporate/VASADENTICITY_12032025113619_Investor_PPT_Q3.pdf) |
| Aug 2025 | [Concall - Aug 2025](https://nsearchives.nseindia.com/corporate/VASADENTICITY_16082025202734_Intimation_of_Investor_PPT_Q1.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_28418_DENTALKART_2024_2025_A_115153431_04092025160611.pdf) |
| from nse | [Financial Year 2024 from nse](https://archives.nseindia.com/annual_reports/SME_AR_26144_DENTALKART_2023_2024_07092024153610.pdf) |
| from nse | [Financial Year 2023 from nse](https://archives.nseindia.com/annual_reports/SME_AR_23019_DENTALKART_2022_2023_28082023191515_08282023200000.zip) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6d88b5c2-3898-439a-829e-f6f0603bbe71.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1495bf7a-cf98-4cdf-a5f9-5b2b420459dc.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c3ff8e75-0989-4e64-b74e-43aed59bc0d4.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/524400/75141524400.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/524400/70309524400.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/524400/65311524400.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/524400/5244000319.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:38:01.253Z.